Use App
Trending
News
Earnings
All
DIA
0.90%
SPY
0.60%
QQQ
0.74%
Trending
BB
16.24%
RGTI
22.28%
BULL
6.81%
IONQ
9.44%
QBTS
18.88%
DELL
16.77%
HYLN
31.91%
UBER
1.69%
FJET
40.78%
PCLA
131.56%
BB
16.24%
RGTI
22.28%
BULL
6.81%
IONQ
9.44%
QBTS
18.88%
DELL
16.77%
HYLN
31.91%
UBER
1.69%
FJET
40.78%
PCLA
131.56%
home
Symbol
INKT
INKT
MiNK Therapeutics Inc
1,801
Mkt Cap
$53.41M
Volume
35,905.00
52W High
$76.00
52W Low
$6.80
PE Ratio
-3.85
INKT Fundamentals
Price
$11.06
Prev Close
$10.94
Open
$10.62
50D MA
$10.97
Beta
0.60
Avg. Volume
54,485.61
EPS (Annual)
-$2.93
P/B
-4.28
Rev/Employee
$0.00
$39.43
PE Ratio
-3.85
Loading...
Loading...
Feed
News
Sentiment
Earnings
Fundamentals
Info
Compact View
Full View
Mini-Chart
Sentiment
Not available
Message Volume
Not available
Advertisement
|
Remove ads.
Latest INKT News
View
Agenus Presents Phase 2 BOT+BAL Melanoma Data Showing Durable Responses and Meaningful Survival in Advanced Checkpoint-Refractory Melanoma at ASCO 2026
Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC
Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer
Top Discussions
top
active
trending
Loading...
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile